Dicyclomine Syrup and Oral Solution and Ibritumomab Intravenous
Determining the interaction of Dicyclomine Syrup and Oral Solution and Ibritumomab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dicyclomine
Brand name: Bentyl, Dibent, Dicyclocot
Synonyms: Dicyclomine
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dicyclomine Syrup and Oral Solution-Ibritumomab Tiuxetan
- Dicyclomine Syrup and Oral Solution-Ibrutinib
- Dicyclomine Syrup and Oral Solution-Ibrutinib Capsules
- Dicyclomine Syrup and Oral Solution-Ibrutinib Tablets
- Dicyclomine Syrup and Oral Solution-Ibu
- Dicyclomine Syrup and Oral Solution-IBU Tablets
- Ibritumomab Intravenous-Dicyclomine Tablets
- Ibritumomab Intravenous-Didanosine
- Ibritumomab Intravenous-Didanosine Delayed-Release Enteric-Coated Capsules
- Ibritumomab Intravenous-Didanosine Oral Solution
- Ibritumomab Intravenous-Didanosine Tablet, for suspension
- Ibritumomab Intravenous-Didrex